Nasal high flow breathing support during exercise for COPD
Part of Lungs & breathing clinical trials.
This study tests whether a special nasal breathing device (nasal high flow) can help people with COPD exercise longer and more comfortably. It compares the device to standard low-flow oxygen or no oxygen at all.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a diagnosis of COPD
- You must be able to walk on your own (no cane, walker, or wheelchair)
- You use low-flow oxygen at 4 liters per minute or less, or no oxygen at all
- You must not be pregnant
- You must not have a pacemaker, defibrillator, or metal implants in your chest
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a special high-flow oxygen device through the nose (called HFNC) can help people with COPD breathe more comfortably during a bronchoscopy, a procedure where a thin tube is placed into the airways to examine the lungs.
This trial tests a smart oxygen system that automatically adjusts oxygen levels for people with COPD who are in the hospital using a nasal high-flow device. It may help keep your oxygen levels stable without needing constant adjustments.
This study tests whether a home high-flow nasal breathing device (myAirvo 3) helps people with COPD who recently needed hospital care for a flare-up. You would use the device at home and track symptoms, oxygen levels, and heart rate daily to see how well it works.
This study looks at how a breathing treatment called nasal high-flow therapy affects lung function over time in people with severe COPD. You'll use a device that delivers warm, moist air through small tubes in your nose while the researchers monitor your breathing. This might help open your airways and make it easier to breathe.
This trial tests whether a special type of oxygen delivered through the nose (high-flow nasal oxygen) helps people hospitalized for a COPD flare-up. It is likely meant for people with significant breathing problems and recent repeat flare-ups.
This trial compares two breathing support methods for people hospitalized with COPD and mild-to-moderate carbon dioxide retention. It aims to see if high-flow nasal oxygen is as effective as the standard mask-based ventilation.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.